Immunexpress Sponsored Session: Sepsis Probability, Antibiotic Stewardship, and Precision Medicine Using SeptiCyte RAPID
Includes a Live Web Event on 04/30/2025 at 11:15 AM (PDT)
Description:
This session is part of the Sepsis Alliance AMR Conference 2025.
In this sponsored session, Dr. Russell Miller, an intensivist at FirstHealth of the Carolinas, explains the challenge of responding to a high number of sepsis alerts and determining which ones require ongoing sepsis care. He describes how a host response assay, SeptiCyte RAPID, recently implemented at FirstHealth, has significantly impacted suspected sepsis patients being admitted from the ED with a sepsis diagnosis. In addition, the SeptiCyte results or probability bands are helping to guide decision making, especially low bands directing away from a sepsis diagnosis or leading to a shortened antibiotic duration. Finally, he speaks to the value of host response testing in precision medicine for sepsis to improve patient outcomes and antimicrobial stewardship.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Session Supporter:
Sepsis Alliance gratefully acknowledges the support of this session provided by Immunexpress.
Russell R. Miller, MD, MPH, FCCM
Medical Director of Critical Care
FirstHealth of the Carolinas
Russell R. Miller III, MD, MPH, FCCM, is an intensivist and Medical Director of Critical Care at FirstHealth of the Carolinas in Pinehurst, NC. Previously, he was Chair of the Critical Care Development Team for Intermountain Healthcare and Director of the Respiratory ICU at Intermountain Medical Center. He did undergraduate training at Duke University, medical and residency training in the southeastern United States, and then a fellowship in Pulmonary and Critical Care Medicine at Vanderbilt. His academic interests have included sepsis, pneumonia and associated lung injury, sedation and delirium in the ICU, and ICU mobility.